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Abstract Magnesium is currently under investigation as a
prospective biodegradable implant material. Biodegrada-
tion of magnesium causes a release of magnesium,
hydroxide ions and hydrogen gas but it can also lead to the
formation of particulate debris. Implant-derived particles
may have immunotoxic effects. To investigate the influence
of magnesium-derived particles on the immune functions of
primary macrophages, up to 500 lg/ml magnesium or
magnesium corrosion particles were added to the cell cul-
ture medium. No major effects were observed on cell via-
bility and on the release of the proinflammatory cytokine
tumor necrosis factor (TNF)a. In addition, the ability of
macrophages to stimulate proliferation of allogenic lym-
phocytes in a mixed leukocyte reaction remained unaf-
fected. When macrophages were incubated with magnesium
particles and then infected with the apathogenic Mycobac-
terium smegmatis, infection-induced TNFa secretion from
murine macrophages was inhibited but not from human
macrophages. However, the bactericidal activity of either
cell type was not influenced. In conclusion, magnesium-
related particles did not restrict the immune function of
macrophages, suggesting that magnesium implants and
corrosion particles derived thereof are highly biocompatible
and have a low inflammatory potential.
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Introduction
The development of magnesium-based implants has
become an intense focus of biomedical research in recent
years (Gu et al. 2009; Moravej and Mantovani 2011;
Purnama et al. 2010; Waizy et al. 2013; Witte et al. 2008).
These implants are biodegradable and offer a number of
unique advantages for temporary applications such as
bone-healing supports. After the healing process is com-
pleted the implant would disintegrate and the surgery for
implant removal would no longer be required, with major
benefits for the patient as well as by reducing the burden on
the healthcare system, thus saving both risks and costs
(Kraus et al. 2012; Staiger et al. 2006). Moreover, per-
manent implant materials and, in particular, implant wear
particles can elicit an inflammatory foreign body response
(Bondarenko et al. 2011; Hallab and Jacobs 2009; Witte
et al. 2007). Such long-term side effects could be avoided
with self-degradable implants. Magnesium and its alloys
are exceptional as potential implant materials since the
mechanical properties are more similar to cortical bone
than polymers or permanent alloys, which could minimize
stress-shielding effects (Staiger et al. 2006). And finally,
self-degrading implants could avoid mechanical stress if
permanent implants were not be removed from pediatric
patients where the tissues are still growing (Hermawan
et al. 2010; Kraus et al. 2012). These properties explain
why magnesium-based biomaterials are primarily investi-
gated for temporary applications such as orthopedic and
cardiovascular implants, e.g., osteosynthetic screws and
plates, intramedullary nails or vessel stents (Hermawan
et al. 2010; Waizy et al. 2013).
However, biodegradability may also pose a problem
since magnesium corrosion may result in particulate debris
and implant-derived corrosion particles may induce pain
and inflammation. Most studies reported appropriate
immunological response to magnesium implants (Badar
et al. 2013; Bondarenko et al. 2011; Feser et al. 2011;
Kraus et al. 2012; Willbold et al. 2011; Witte et al. 2007)
but excess degradation rates have been associated with
increased immune cell infiltration (Dziuba et al. 2013;
Erdmann et al. 2010). In a recent study the bone tissue
response was evaluated after complete degradation of a
ZEK100 magnesium alloy implant and the authors reported
severe pathological alterations with elevated numbers of
inflammatory cells, such as osteoclasts, macrophages and
giant cells (Dziuba et al. 2013). Both ion release and wear
debris from permanent implants can activate macrophages
and osteoclasts to induce inflammation and osteolysis and
eventually lead to implant failure (Hallab and Jacobs
2009). Co–Cr–Mo alloy particles have been shown to
increase the release of inflammatory cytokines such as
TNFa from monocytes and macrophages (Caicedo et al.
2009, 2010) and induce apoptosis of cultured osteocytes
(Kanaji et al. 2009). Likewise, titanium particles were
shown to have negative effects on osteoblasts and macro-
phages (Fritz et al. 2002; Lee et al. 2012; Mao et al. 2012).
Considering that magnesium-containing microparticles
have been reported to be released from corroding implants
in vivo (Badar et al. 2013) and the fact that they have also
been observed in phagocytes (Bondarenko et al. 2011;
Witte et al. 2007), it is mandatory to assess the potential of
magnesium-derived particles for immunological effects.
Little is known about cytotoxic and genotoxic effects of
magnesium particles (Di Virgilio et al. 2011; Grillo et al.
2011). Magnesium ions and degradation extracts do not
appear to interfere significantly with antigen-presenting
cells (Feser et al. 2011) but so far the immunotoxic
potential of particulate corrosion products has not been
assessed. The aim of this study was to investigate the
effects of magnesium particles as well as magnesium cor-
rosion particles on primary cells of the innate immune
system and elucidate whether their immunocompetence
might be affected.
Materials and methods
Primary murine macrophages
Husbandry and handling of mice used for the generation of
cells was done according to German animal welfare regu-
lations. Bone marrow-derived macrophages were generated
from the bone marrow of 8–20-week-old female BALB/c
mice using a modified version of the protocol of Lutz et al.
(1999). Briefly, the femur was explanted, both ends were
cut and the bone marrow was flushed with 5 ml sterile
phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM
KCl, 8 mM Na2HPO4, 1.7 mM KH2PO4, pH 7.4; salts
from Merck KGgA, Darmstadt, Germany). The cells were
then pelleted via centrifugation and resuspended in culture
medium consisting of RPMI 1640 medium (Biochrom AG,
Berlin, Germany) supplemented with 10 % FBS, 100 IU/
ml penicillin, 100 lg/ml streptomycin (all PAA Labora-
tories, Pasching, Austria) and 50 lM 2-mercaptoethanol
(Sigma–Aldrich GmbH, Steinheim, Germany). Cells were
then seeded in a 10-cm dish (Cell?, Sarstedt AG,
Nu¨mbrecht, Germany) at a density of approx. 40,000/cm2
and stimulated with 20 ng/ml murine granulocyte macro-
phage colony-stimulating factor (GM-CSF, R&D Systems,
Wiesbaden, Germany) to induce differentiation into den-
dritic cells and macrophages. Culture was continued for
9 days and fresh culture medium with GM-CSF was added
on days 3, 6 and 8. On day 9, the supernatant containing the
dendritic cells was removed and RPMI containing FBS and
antibiotics was added. The adherent macrophages were
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scraped off the dishes on day 14, reseeded in a 12-well
plate (Greiner Bio-One GmbH, Frickenhausen, Germany)
at 200,000 cells/well in 1 ml medium and incubated for at
least 4 h to assure attachment before experiments were
started.
Primary human macrophages
Peripheral blood mononuclear cells (PBMC) were isolated
from the buffy coats of peripheral blood from anonymous
healthy donors (kindly provided by the Hannover Medical
School) according to Kasraie et al. (2010) with some
modifications. Briefly, PBMC were obtained via density-
gradient centrifugation using Pancoll human (PAN-Bio-
tech, Aidenbach, Germany) and seeded in a 10-cm dish at
approximately 160,000 cells/cm2 in Iscove Basal Medium
(Biochrom) supplemented with 4 % human AB serum
(PAN-Biotech), 1 % non-essential amino acids (Biochrom),
2 mM L-glutamine (PAA), 100 IU/ml penicillin, 100 lg/ml
streptomycin and 50 lg/ml gentamicin (PAA). Cells were
incubated at 37 C and 5 % CO2 for 1 h before washing five
times with sterile PBS. The remaining adherent cells were
mainly monocytes which were then incubated for 7 days in
RPMI medium (PAA) containing 5 % FCS, 12 mM HEPES
(Life Technologies, Darmstadt, Germany), 2 mM L-gluta-
mine, 100 IU/ml penicillin, 100 lg/ml streptomycin and
10 ng/ml granulocyte macrophage colony-stimulating fac-
tor (Leukine, Bayer HealthCare Pharmaceuticals, Berlin,
Germany) to induce differentiation into macrophages.
After this period, cells were collected via scraping and
reseeded in a 12-well plate at 200,000 cells/well in 1 ml
medium and incubated for at least 4 h to assure attachment.
Non-adherent cells were removed with the medium and
experiments were started.
Treatment
Murine macrophages were treated with 20, 50, 100 or
500 lg/ml pure magnesium (Mg) particles (Omikron,
Neckarwestheim, Germany) or magnesium corrosion par-
ticles (MCP) derived from pure Mg granulate (Riedel–de
Haen, Seelze, Germany). To mimic magnesium degrada-
tion under physiological conditions 1 g Mg granulate was
filled in a 15-ml Falcon tube and 5 ml PBS was added. The
corrosion was allowed to proceed at ambient temperatures
for 3 days. Then the supernatant was discarded and the
remaining metallic magnesium together with the insoluble
corrosion products was allowed to dry at ambient condi-
tions. EDX analysis (Hitachi S-3400 scanning electron
microscope, 15 keV, viewing distance about 10 mm) of
the resulting powder detected Mg and O exclusively.
Human macrophages were treated with 5, 10, 50, 100 or
500 lg/ml Mg, MCP or cobalt–chromium–molybdenum
(CCM) particles. In some experiments cells were stimu-
lated with 1 lg/ml lipopolysaccharide (LPS) O127:B8
(Sigma–Aldrich) to confirm TNFa-releasing capacity
(results not shown).
After 24 h of incubation culture supernatants were col-
lected, centrifuged at 3,000g for 5 min at 4 C and the
resulting supernatant was stored at -80 C until further
analysis.
Scanning electron microscopy (SEM)
The structure of the different particles was determined
using a JXA-8900R electron probe microanalyser (EPMA;
JEOL GmbH, Eching, Germany). Here, the Rutherford
backscattering spectrometry (RBS) mode was chosen to
obtain best results. To determine a single grain’s dimen-
sion, self-adhesive carbon pads (Lighttabs; Plano GmbH,
Wetzlar, Germany) were strewn with the particles resulting
in a singular layer on the pad’s surface. Using a magnifi-
cation of 2009 or 25009, respectively, single grains
became clearly visible. Dimensions of the grains were
measured using the microanalyser’s integrated measure-
ment tool.
Magnesium concentration, metabolic activity
and cytokine analysis
Supernatant magnesium concentration was measured
colorimetrically using a commercial assay kit (Nanocolor
Ha¨rte 20, Macherey–Nagel, Du¨ren, Germany) as previ-
ously described (Schumacher et al. 2011). To determine
cell viability after particle treatment particle medium was
removed and fresh medium supplemented with 20 %
CellTiter96 AQueous One Solution (Promega, Mann-
heim, Germany) was added to the culture wells and
incubated for 1 h at 37 C at 5 % CO2. During this
period metabolic activity of living cells led to a color
change which was then quantified by measuring optical
density at 490 nm using a microplate reader (MRX;
Dynatech, Denkendorf). Murine tumor necrosis factor
alpha (TNFa) or human TNFa, concentrations were
determined using commercial assay kits (DuoSet ELI-
SAs; R&D Systems, Wiesbaden, Germany) according to
the manufacturer’s instructions. In cases where the cal-
culated concentrations were below the limit of quantifi-
cation of the assay kits, a value of (0.5 x lowest standard
concentration of 31.25 pg/ml) was used for the statistical
calculations. This applied to 26 out of 60 samples
measured with the murine ELISA.
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Mixed leukocyte reaction
T cells were isolated from the spleens of female NMRI mice
as previously described (Baumer et al. 2010). Briefly,
spleens were flushed with sterile PBS, the cell suspension
was centrifuged and the pellet resuspended in an erythro-
cyte lysis buffer (155 mM NH4Cl, 0.1 mM Na2EDTA,
10 mM NaHCO3, pH 7.3) and incubated for 5 min. After
two washing steps cells were seeded in RPMI (PAA) con-
taining 10 % FBS, 100 IU/ml penicillin and 100 lg/ml
streptomycin in a 10-cm dish and incubated for 2–3 h to
enrich T cells in the supernatant. Non-adherent cells were
then collected and stained with 0.5 lM carboxyfluorescein
succinimidyl ester (CFSE; Invitrogen, Karlsruhe, Germany)
for 10 min followed by three washings. Murine macro-
phages were isolated as described above and incubated for
24 h with Mg, MCP or CCM particles at a concentration of
100 lg/ml. 104 macrophages were then incubated with 105
CFSE-stained lymphocytes in a U-bottom 96-well plate
(Greiner) for 4–5 days before T cell proliferation was
analyzed by flow cytometry (Coulter Epics XL and CXP
Analysis software, Beckman Coulter, Miami, USA).
Evaluation of immunocompetence
Immune function of murine and human macrophages was
tested using a modified version of the protocol according to
Kuehnel et al. (2001). After 24-h incubation of the cells
with different particle concentrations, supernatants were
removed and cells were infected with apathogenic Myco-
bacterium smegmatis [M. smegmatis; strain mc2155
(ATCC 19420)] which was cultured and prepared for
infection as described previously (Kuehnel et al. 2001).
Macrophages were incubated with a mycobacterial sus-
pension of an OD660 nm of 0.2 in antibiotic-free medium
representing MOI of *10:1 for 2 h to allow intracellular
penetration. After that, non-ingested mycobacteria were
removed by several washing steps and remaining extra-
cellular mycobacteria were killed by addition of 100 lg/ml
gentamicin (Carl-Roth, Karlsruhe, Germany) for 1 h before
cells were incubated with the respective treatment particle
suspensions for further 20 h. Then, culture supernatants
were again collected for cytokine measurements and
macrophages were scraped and lysed in 1 % sodium
dodecyl sulfate (SDS, Sigma–Aldrich) in PBS using a 23G
needle (B. Braun, Melsungen, Germany) to release
phagocytosed mycobacteria. Lysates were seeded on
lysogeny broth (LB) agar plates (10 g/l tryptone, 5 g/l
yeast extract, 10 g/l NaCl, 10 g/l agar–agar; Carl-Roth,
Karlsruhe, Germany) and incubated for 6 days at 37 C
and 5 % CO2 before colony-forming units were counted.
The initial mycobacterial suspension for infection was
diluted and plated equally as a positive control.
Statistical analysis
The treatment groups were checked for statistically sig-
nificant differences using one-way ANOVA followed by
Dunnett’s multiple comparison post hoc test. Statistical
Fig. 1 SEM images of particles. Scanning electron microscopy
images of Mg particles (a), magnesium corrosion particles (b) and
CCM particles (c) at 2009 (a, b) or 25009 (c) magnification,
respectively
24 Prog Biomater (2015) 4:21–30
123
analysis was done using Prism software 5.01 (GraphPad
Software, La Jolla, USA) and results of p \ 0.05 were
considered statistically significant.
Results
Biocompatibility
SEM analysis revealed that Mg and magnesium corrosion
particles were more or less round with an approximate size
between 20 and 100 lm, although we also observed some
MCP that were well below 10 lm. In contrast, the majority
of CCM particles were smaller than 10 lm and their sur-
face was much rougher and sharp edged (Fig. 1).
To test for a cytotoxic effect of the particles we deter-
mined metabolic activity as a parameter for cell viability.
After 24 h of incubation with different particle concentra-
tions, metabolic activity of both murine and human mac-
rophages remained largely unchanged with the exception
of the 500 lg/ml doses of MCP in murine and CCM par-
ticles in human cells, which led to a 39 or 30 % reduction
in viability, respectively (Fig. 2a, b). This result was con-
trary to the degree of degradation as higher amounts of
magnesium ions were released from Mg versus magnesium
corrosion particles (Table 1) and the pH was also slightly
higher (8.36 vs. 8.19 for the 500 lg/ml doses).
We next determined the concentration of TNFa in the
culture supernatants to assess whether the particles would
elicit an inflammatory response. Unstimulated cytokine
secretion from murine macrophages was below the limit of
detection for all treatments. In contrast, human macro-
phages produced measurable amounts of TNFa but only
the highest concentration of CCM particles (500 lg/ml)
caused a significant increase (Fig. 2c).
Immune function
Macrophages have very important functions as cells of the
innate immune system. Infection of macrophages with the
intracellular mycobacterium M. smegmatis leads to an
immune response with increased production of TNFa
(Roach and Schorey 2002), so we tested whether particle
incubation would diminish this effect. Indeed, Mg and
magnesium corrosion particles dose dependently reduced
cytokine release from murine macrophages, with MCP
being the more potent agent (Fig. 3a). Notably, viability of
murine macrophages was decreased by about 50 % after M.
smegmatis infection of cells that had been treated with
MCP or 100–500 lg/ml Mg particles, indicating that the
combined effect of these two stressors overwhelmed
resistance of the cells and that MCP had a stronger negative
impact (see Additional file 1).
Interestingly, the result was completely different when
human cells were infected since magnesium-based parti-
cles did not lead to significant inhibition (Fig. 3b). The
higher concentrations of CCM particles, however, resulted
Fig. 2 Biocompatibility of particles. Murine or human macrophages
were incubated for 24 h with media containing indicated amount of
magnesium particles (Mg), magnesium corrosion particles (MCP) or
cobalt–chromium–molybdenum particles (CCM). Untreated cells
served as a control (Co). a Metabolic activity, mean ± SD of
n = 3–6. b Metabolic activity, mean ± SD of n = 8. c TNFa
concentration, mean ± SD of n = 7. ANOVA, ** p \ 0.01, ***
p \ 0.001 compared to control cells
Table 1 Magnesium concentration of treatment supernatants
Treatment (lg/ml) Mg MCP
20 50 100 500 20 50 100 500
Magnesium conc. (mM) 0.5 ± 0.2 1.2 ± 0.5 2.6 ± 0.6 10.8 ± 2.8 0.4 ± 0.3 0.6 ± 0.6 1.7 ± 1.9 3.6 ± 0.5
Magnesium concentration of supernatants after treatment with particle media containing indicated amount of magnesium-based particles,
Mean ± SD of n = 3
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in decreased cytokine production, although this finding
was not statistically significant due to the noise in the
data.
Beside their innate immune function macrophages can
also act as antigen-presenting cells and thus induce the
proliferation of allogenic T cells in a mixed leukocyte
reaction. We investigated whether abraded magnesium
degradation products might interfere with this process.
Neither the two kinds of magnesium particles nor the CCM
particles led to a significant change of T cell proliferation
(Fig. 4; Table 2).
To fight a mycobacterial infection macrophages need to
be able to kill invading mycobacteria. Macrophages pre-
treated with the different particles for 24 h were lysed 20 h
after infection with M. smegmatis and plated on LB agar.
Irrespective of species, particle type and concentration we
did not observe any mycobacterial growth (Fig. 5, see also
Additional file 2) indicating that the cells retained their
bactericidal activity.
Discussion
Magnesium and magnesium-based alloys are currently
under intense investigation for the development of biode-
gradable implants (Moravej and Mantovani 2011; Seitz
et al. 2014; Waizy et al. 2013). The degradation process
begins when magnesium comes into contact with body
fluids. Several kinds of degradation products have been
suggested to be biologically relevant, i.e., magnesium ions
and alloy metal ions, hydroxide ions, hydrogen gas and
abraded particles (Gu et al. 2009). Magnesium ions are
essential and highly biocompatible; hydroxide ions are
thought to be buffered to maintain a physiological pH
while excessive hydrogen evolution can lead to air pockets
in the tissue. Particulate implant debris can induce the
production of proinflammatory mediators and pathologies
like aseptic implant loosening (Hallab and Jacobs 2009;
Kaufman et al. 2008). In the present study we investigated
whether magnesium-based particles could affect immune
functions of macrophages. Macrophages are among the
first cells to arrive at the site of injury where they modulate
inflammatory and wound healing processes (Koh and
DiPietro 2011). They also take up particulate debris which
may result in an inflammatory response (Hallab and Jacobs
2009).
Here, the effects of magnesium-based particles on
macrophage viability were minor except when excessive
amounts of magnesium corrosion particles were added.
Previous studies also reported cytotoxic effects of exces-
sive amounts of Mg particles on a rat osteosarcoma cell
line (Di Virgilio et al. 2011; Grillo et al. 2011). The reason
for this outcome in our study is unclear as it appeared to be
independent of magnesium ion concentration and pH.
However, it seems conceivable that this effect might be
associated with the heterogeneous size distribution of MCP
(comprising a number of particles in the low lm range; see
Fig. 1) compared to magnesium particles, because particle
size has been suggested to be an important determinant of
inflammatory potency (Caicedo et al. 2013; Hallab and
Jacobs 2009). Co–Cr–Mo particles have been shown to
increase the release of proinflammatory cytokines such as
TNFa from human monocytes/macrophages (Caicedo et al.
2009, 2010), so we used this particle type as a positive
control for our experiments using human macrophages.
TNFa can be used as a surrogate marker for an inflam-
matory response because it is known to play an important
role in the orchestration of multiple proinflammatory
cytokines (Feldmann and Maini 2003; Parameswaran and
Patial 2010). This cytokine was not detectable in the
supernatants of murine macrophages treated with magne-
sium-based particles suggesting that these particles alone
are not proinflammatory. Likewise, in human macrophages
CCM particles led to an increase in TNFa secretion,
Fig. 3 TNFa release from infected macrophages. Murine or human
macrophages were incubated for 24 h with media containing either no
particles (Co) or indicated amount of magnesium particles (Mg),
magnesium corrosion particles (MCP) or cobalt–chromium–molyb-
denum particles (CCM) before infection with Mycobacterium
smegmatis. Particle incubation was then continued for further 20 h.
a Mean ± SD of n = 6–8. b Mean ± SD of n = 5. ANOVA,
*p \ 0.05 compared to untreated control cells. Changes in panel b
were not statistically significant
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whereas magnesium-based particles did not. Considering
the moderate release of magnesium ions from the particles
this finding is in accordance with a previous study report-
ing that magnesium ions did not increase TNFa secretion
from dendritic cells (Feser et al. 2011).
It is worth noting that CCM particles were smaller and
more sharp edged than the magnesium-derived particles
used in this study. It has been suggested that debris must be
phagocytosable, i.e., less than 10 lm, to induce an
inflammatory response, and that irregular surface structures
are more inflammatory than smooth ones (Caicedo et al.
2013; Hallab and Jacobs 2009). These features likely
explain the inflammatory potential of CCM particles. At
least a subset of the Mg corrosion particles also met these
physical criteria but yet they did induce a significant
secretion of TNFa. One explanation may be that the
ongoing corrosion may have mitigated the proinflamma-
tory potential of the magnesium corrosion particles.
Moreover, it has been reported that CCM particles activate
Fig. 4 Mixed leukocyte reaction. Murine macrophages were treated
for 24 h with media containing 100 lg/ml of indicated particles or
media without particles before having been incubated with CFSE-
stained lymphocytes. Representative histograms of three independent
experiments showing percentage of proliferated cells
Table 2 Mixed leukocyte reaction
Treatment Control
(untreated)
Mg MCP CCM
Proliferated
cells (%)
62.7 ± 0.9 65.2 ± 2.0 66.6 ± 5.7 66.0 ± 4.2
Proliferated lymphocytes after coincubation with particle-treated
macrophages, Mean ± SD of n = 3
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the inflammasome (Caicedo et al. 2009) thus triggering the
release of proinflammatory mediators. MCP may lack this
property but this remains to be tested in future investiga-
tions. Macrophages are essential effectors of innate
immunity and it is, therefore, of utter importance that they
maintain their functionality even after the ingestion of
implant debris. Apart from their phagocytic activity these
cells can process and present antigen to other immune
cells, thus triggering the adaptive immune responses
(Schenk et al. 2014; Unanue et al. 1969). Here, pretreat-
ment with magnesium particles did neither enhance nor
inhibit proliferation of allogenic T cells in a mixed leu-
kocyte reaction, indicating unchanged T cell response. This
is in agreement with previous findings where soluble
magnesium degradation products did not affect the in vitro
immunogenicity of primary dendritic cells (Feser et al.
2011). Notably, the same was true for CCM particles,
which corresponds to previous observations that, unlike
soluble metal ions, Co–Cr–Mo debris failed to upregulate
costimulatory molecules on monocytes (Caicedo et al.
2010).
Among the essential tasks of macrophages is the killing
of invading bacteria so any restriction of this ability due to
biomaterial implantation must be avoided. Mycobacterial
infection of macrophages induces cytokine production and
enhances the phagosomal superoxide burst to fight the
pathogen (Podinovskaia et al. 2013; Roach and Schorey
2002). After incubation with particles both human and
murine macrophages retained bactericidal activity, indi-
cating that this important antibacterial activity was not
compromised by magnesium degradation products. Inter-
estingly, TNFa production after infection showed species-
specific differences. After incubation with magnesium-
derived particles, TNFa was diminished in mouse cells but
not in human macrophages. Similar distinctions between
murine and human macrophages have been observed pre-
viously (Podinovskaia et al. 2013). Human data showed a
remarkable degree of variability which might be due to
between-donor variation or to unrecognized, subclinical
affections of some blood donors. However, there was not
even a tendency towards reduced TNFa levels after pre-
treatment with magnesium-derived particles plus infection.
Thus, the differences we observed may rather be linked to
the decreased viability of murine cells after particle contact
plus infection. If the cells became damaged early after
infection, they may have not been able to produce signifi-
cant amounts of TNFa afterwards. Unfortunately, the lim-
ited availability of human blood products did not allow us to
test the viability of human macrophages after infection.
Apart from the above mentioned, the contrasting results
may also be due to differences in the macrophage isolation
procedures between mice and men (bone marrow derived
vs. blood derived) or to species-specific properties as
exemplified by a recent study providing evidence of sig-
nificant dissimilarities in the genomic response of inflam-
matory diseases (Seok et al. 2013). Irrespective of the actual
reason, the fact that all macrophages remained capable of
killing intracellular microorganisms suggests that a dimin-
ished TNFa response did not have major detrimental effects
on the overall immune function of the cells.
Conclusions
In the present study immunomodulatory effects of partic-
ulate magnesium implant debris on primary macrophages
Fig. 5 Absence of mycobacterial growth. Human macrophages were
incubated for 24 h with media containing indicated amount of
particles before infection with Mycobacterium smegmatis. Particle
incubation was then continued for further 20 h before cells were
lysed, seeded on Lysogeny broth agar plates and incubated for 6 days.
Panel a shows growth of Mycobacterium smegmatis. The plate in
panel b is representative of at least five independent experiments
using human or murine macrophages, respectively. No colony-
forming units were observed in any of the experiments after any
particle treatment
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were investigated. The particles were biocompatible and
induced neither an exaggerated immune reaction nor did
they reveal any immunosuppressive properties. In agree-
ment with in vivo observations, magnesium implant debris
did not affect relevant immune functions of macrophages.
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